[HTML][HTML] TRAF molecules in cell signaling and in human diseases

P Xie - Journal of molecular signaling, 2013 - Springer
The tumor necrosis factor receptor (TNF-R)-associated factor (TRAF) family of intracellular
proteins were originally identified as signaling adaptors that bind directly to the cytoplasmic …

TNF receptor associated factor 2 (TRAF2) signaling in cancer

D Siegmund, J Wagner, H Wajant - Cancers, 2022 - mdpi.com
Simple Summary Tumor necrosis factor (TNF) receptor associated factor-2 (TRAF2) is an
intracellular adapter protein with E3 ligase activity, which interacts with a plethora of other …

Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia

J Klintman, N Appleby, B Stamatopoulos… - Blood, The Journal …, 2021 - ashpublications.org
The transformation of chronic lymphocytic leukemia (CLL) to high-grade B-cell lymphoma is
known as Richter syndrome (RS), a rare event with dismal prognosis. In this study, we …

Genetic alterations of TRAF proteins in human cancers

S Zhu, J Jin, S Gokhale, AM Lu, H Shan… - Frontiers in …, 2018 - frontiersin.org
The tumor necrosis factor receptor (TNF-R)-associated factor (TRAF) family of cytoplasmic
adaptor proteins regulate the signal transduction pathways of a variety of receptors …

Transient systemic autophagy inhibition is selectively and irreversibly deleterious to lung cancer

K Khayati, V Bhatt, T Lan, F Alogaili, W Wang, E Lopez… - Cancer research, 2022 - AACR
Autophagy is a conserved catabolic process that maintains cellular homeostasis. Autophagy
supports lung tumorigenesis and is a potential therapeutic target in lung cancer. A better …

Targeting signaling factors for degradation, an emerging mechanism for TRAF functions

XD Yang, SC Sun - Immunological reviews, 2015 - Wiley Online Library
Tumor necrosis factor receptor (TNFR)‐associated factors (TRAF s) form a family of proteins
that are best known as signaling adapters of TNFR s. However, emerging evidence …

Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma

C Otto, M Giefing, A Massow, I Vater… - British journal of …, 2012 - Wiley Online Library
Summary Hodgkin and Reed/Sternberg (HRS) cells in classical H odgkin lymphoma (cHL)
show constitutive activation of nuclear factor (NF)‐κB. Several genetic lesions contribute to …

TRAF3 as a multifaceted regulator of B lymphocyte survival and activation

GA Bishop, LL Stunz, BS Hostager - Frontiers in immunology, 2018 - frontiersin.org
The adaptor protein TNF receptor-associated factor 3 (TRAF3) serves as a powerful
negative regulator in multiple aspects of B cell biology. Early in vitro studies in transformed …

An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression

B Zhang, DP Calado, Z Wang, S Fröhler, K Köchert… - Cell reports, 2015 - cell.com
Diffuse large B cell lymphoma (DLBCL) is a complex disease comprising diverse subtypes
and genetic profiles. Possibly because of the prevalence of genetic alterations activating …

Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice

AI Lalani, CR Moore, C Luo, BZ Kreider… - The Journal of …, 2015 - journals.aai.org
Myeloid cells, including granulocytes, monocytes, macrophages, and dendritic cells, are
crucial players in innate immunity and inflammation. These cells constitutively or inducibly …